𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Performance evaluation of the FACSCount system: A dedicated system for clinical cellular analysis

✍ Scribed by K. Strauss; I. Hannet; S. Engels; A. Shiba; D. M. Ward; S. Ullery; M. G. Jinguji; J. Valinsky; D. Barnett; A. Orfao; L. Kestens


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
675 KB
Volume
26
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.

✦ Synopsis


Flow cytometers are instruments that can determine multiparameter data simultaneously and have a great potential in providing unique information about cells. The FACSCount System is designed as the first dedicated flow cytometer for the clinical laboratory. Its current configuration provides CD4, CD8, and CD3 absolute counts from 100 pI of whole blood. Adapting the FACSCount System to the clinical setting are minimal sample handling, lysis free cell preparation, automated fluorescence gating, built-in calibrated reference beads, and appropriate error code reporting. Quality control checks ensure that reported CD4 counts, important for clinical follow-up and patient management, are accurate, precise, and reproducible across instruments over time. Q 1996 Wiley-Liss, Inc.


πŸ“œ SIMILAR VOLUMES


A System for Evaluating Performance and
✍ Martin C. Herbordt; Jade Cravy; Renoy Sam; Owais Kidwai; Calvin Lin πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 424 KB

SIMD arrays are likely to become increasingly important as coprocessors in domain specific systems as architects continue to leverage RAM technology in their design. The problem this work addresses is the efficient evaluation of SIMD arrays with respect to complex applications while accounting for o

A critique of the World Health Organisat
✍ Jeff Richardson; John Wildman; Iain K. Robertson πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 146 KB

## Abstract The World Health Organisation's (WHO) approach to the measurement of health system efficiency is briefly described. Four arguments are then presented. First, equity of finance should not be a criterion for the evaluation of a health system and, more generally, the same objectives and im